d-alpha tocopherol has been researched along with Berger Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balla, G; Balla, J; Heidland, A; Jenei, V; Kovács, T; Nagy, J; Schinzel, R; Varga, Z; Vas, T; Wagner, Z; Wittmann, I | 1 |
| Ong-ajyooth, L; Ong-ajyooth, S; Parichatikanond, P | 1 |
| Alon, US; Chan, JC; Flynn, JT; Lande, MB; Mahan, JD; Norkus, EP; Scheinman, J; Trachtman, H; Weiss, RA | 1 |
| Kovács, T; Nagy, J; Wittmann, I | 1 |
| Chan, JC; Trachtman, H | 1 |
| Chan, JC; Chiu, MC; Hisano, S | 1 |
| Coppo, R | 1 |
| Angelin, B; Berglund, L; Bergström, J; Björkhem, I; Diczfalusy, U; Pettersson, EE; Rekola, S; Sundqvist, KG | 1 |
| Chan, JC; Krieg, RJ; Rodriguez, GE; Tokieda, K; Yi, ZW | 1 |
| Brandt, R; Chan, JC; Chan, W; Futterweit, S; Ma, C; Maesaka, J; Trachtman, H; Valderrama, E; Wakely, P | 1 |
| Chan, JC; Langman, CB; Lin, CY; Scheinman, JI; Trachtman, H | 1 |
| Chan, JC; Chan, W; Krieg, RJ; Norkus, EP | 1 |
| Chan, JC; Chan, W; Krieg, RJ; Kuemmerle, NB; Norkus, EP; Trachtman, H | 2 |
3 review(s) available for d-alpha tocopherol and Berger Disease
| Article | Year |
|---|---|
Modulating the progression in IgA nephropathy.
Topics: Adolescent; Adrenal Cortex Hormones; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Child; Combined Modality Therapy; Disease Progression; Fish Oils; Glomerulonephritis, IGA; Humans; Kidney Failure, Chronic; Tonsillectomy; Vitamin E | 2006 |
Pediatric IgA nephropathy: clinical and therapeutic perspectives.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Child; Contraindications; Disease Progression; Follow-Up Studies; Glomerulonephritis, IGA; Hematuria; Humans; Proteinuria; Randomized Controlled Trials as Topic; Steroids; Tonsillectomy; Vitamin E; Vitamins | 2008 |
IgA nephropathy: to treat or not to treat?
Topics: Animals; Antigen-Antibody Complex; Antioxidants; Disease Models, Animal; Fish Oils; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Glomerulus; Prognosis; Vitamin E | 1997 |
2 trial(s) available for d-alpha tocopherol and Berger Disease
| Article | Year |
|---|---|
Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study.
Topics: Adolescent; Antioxidants; Child; Double-Blind Method; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Male; Pilot Projects; Placebos; Prospective Studies; Proteinuria; Treatment Outcome; Vitamin E | 2003 |
Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study.
Topics: Administration, Oral; Adult; Cytokines; Double-Blind Method; Fatty Acids, Omega-3; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Lipids; Lipoproteins; Male; Middle Aged; Prospective Studies; Proteinuria; Vitamin E | 1994 |
9 other study(ies) available for d-alpha tocopherol and Berger Disease
| Article | Year |
|---|---|
Oxidative stress and non-enzymatic glycation in IgA nephropathy.
Topics: Adult; alpha-Tocopherol; Female; Glomerulonephritis, IGA; Glycation End Products, Advanced; Glycosylation; Humans; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress | 2005 |
The effect of alpha-tocopherol on the oxidative stress and antioxidants in idiopathic IgA nephropathy.
Topics: alpha-Tocopherol; Antioxidants; Case-Control Studies; Female; Glomerulonephritis, IGA; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidative Stress; Prospective Studies; Time Factors | 2006 |
Renal protection in IgA nephropathy requires strict blood pressure control.
Topics: Animals; Blood Pressure; Glomerulonephritis, IGA; Humans; Kidney; Renal Circulation; Vitamin E | 2005 |
[IgA nephropathy: modulation of progression by vitamin E, tonsillectomy, steroid and cytotoxic].
Topics: Disease Progression; Glomerulonephritis, IGA; Humans; Steroids; Tonsillectomy; Vitamin E | 2007 |
Rat macrophages in experimental IgA nephropathy.
Topics: Animals; Cattle; Cells, Cultured; Female; gamma-Globulins; Glomerulonephritis, IGA; Kinetics; Macrophages, Peritoneal; Male; Proteinuria; Rats; Rats, Inbred Lew; Reference Values; Superoxides; Vitamin E | 1996 |
Vitamin E ameliorates renal injury in an experimental model of immunoglobulin A nephropathy.
Topics: Animals; Antioxidants; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Cattle; Food, Fortified; gamma-Globulins; Glomerulonephritis, IGA; Hematocrit; Humans; Kidney; Kidney Cortex; Liver; Male; Proteinuria; Rats; Rats, Inbred Lew; Sodium; Transforming Growth Factor beta; Vitamin E | 1996 |
alpha-Tocopherol reduces proteinuria, oxidative stress, and expression of transforming growth factor beta 1 in IgA nephropathy in the rat.
Topics: Animals; Blotting, Northern; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Glomerulonephritis, IGA; Male; Malondialdehyde; Oxidative Stress; Proteinuria; Rats; Rats, Inbred Lew; RNA, Messenger; Transforming Growth Factor beta; Vitamin E; Weight Gain | 1998 |
Effects of fish oil and alpha-tocopherol in immunoglobulin A nephropathy in the rat.
Topics: Animals; Cattle; Dietary Fats; Fish Oils; gamma-Globulins; Glomerulonephritis, IGA; Kidney; Kidney Glomerulus; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta; Vitamin E | 1998 |
Influence of alpha-tocopherol over the time course of experimental IgA nephropathy.
Topics: Animals; Blotting, Northern; Cattle; Diet; Glomerular Mesangium; Glomerulonephritis, IGA; Immunoglobulin A; Male; Malondialdehyde; Mycobacterium bovis; Oxidative Stress; Proteinuria; Rats; Rats, Inbred Lew; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Vitamin E | 1999 |